TY - JOUR
T1 - Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease
T2 - a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group
AU - Shen, Bo
AU - Kochhar, Gursimran S.
AU - Navaneethan, Udayakumar
AU - Cross, Raymond K.
AU - Farraye, Francis A.
AU - Iacucci, Marietta
AU - Schwartz, David A.
AU - Gonzalez-Lama, Yago
AU - Schairer, Jason
AU - Kiran, Ravi P.
AU - Kotze, Paulo Gustavo
AU - Kobayashi, Taku
AU - Bortlik, Martin
AU - Liu, Xiuli
AU - Levy, Alexander N.
AU - González Suárez, Begoña
AU - Tang, Shou Jiang
AU - Coelho-Prabhu, Nayantara
AU - Lukas, Martin
AU - Bruining, David H.
AU - El-Hachem, Sandra
AU - Charles, Roger J.
AU - Chen, Yan
AU - Sood, Ajit
AU - Mao, Ren
AU - Loras, Carme
AU - Dulai, Parambir S.
AU - Picoraro, Joseph A.
AU - Chiorean, Michael
AU - Lukas, Milan
AU - Shergill, Amandeep
AU - Silverberg, Mark S.
AU - Sandborn, William J.
AU - Bernstein, Charles N.
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/6
Y1 - 2021/6
N2 - The majority of patients with Crohn's disease and a proportion of patients with ulcerative colitis will ultimately require surgical treatment despite advances in diagnosis, therapy, and endoscopic interventions. The surgical procedures that are most commonly done include bowel resection with anastomosis, strictureplasty, faecal diversion, and ileal pouch. These surgical treatment modalities result in substantial alterations in bowel anatomy. In patients with inflammatory bowel disease, endoscopy plays a key role in the assessment of disease activity, disease recurrence, treatment response, dysplasia surveillance, and delivery of endoscopic therapy. Endoscopic evaluation and management of surgically altered bowel can be challenging. This consensus guideline delineates anatomical landmarks and endoscopic assessment of these landmarks in diseased and surgically altered bowel.
AB - The majority of patients with Crohn's disease and a proportion of patients with ulcerative colitis will ultimately require surgical treatment despite advances in diagnosis, therapy, and endoscopic interventions. The surgical procedures that are most commonly done include bowel resection with anastomosis, strictureplasty, faecal diversion, and ileal pouch. These surgical treatment modalities result in substantial alterations in bowel anatomy. In patients with inflammatory bowel disease, endoscopy plays a key role in the assessment of disease activity, disease recurrence, treatment response, dysplasia surveillance, and delivery of endoscopic therapy. Endoscopic evaluation and management of surgically altered bowel can be challenging. This consensus guideline delineates anatomical landmarks and endoscopic assessment of these landmarks in diseased and surgically altered bowel.
UR - http://www.scopus.com/inward/record.url?scp=85106217166&partnerID=8YFLogxK
U2 - 10.1016/S2468-1253(20)30394-0
DO - 10.1016/S2468-1253(20)30394-0
M3 - Review article
C2 - 33872568
AN - SCOPUS:85106217166
SN - 2468-1253
VL - 6
SP - 482
EP - 497
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 6
ER -